High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial (Q35057869)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial |
scientific article |
Statements
1 reference
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial (English)
1 reference
Petra Muus
1 reference
Stefan Suciu
1 reference
Dominik L D Selleslag
1 reference
Constantijn J M Halkes
1 reference
Domenico Magro
1 reference
Paola Fazi
1 reference
Lorella Melillo
1 reference
Francesco Fabbiano
1 reference
Giovanna Meloni
1 reference
Anne Hagemeijer
1 reference
Daniela Cilloni
1 reference
Liv Meert
1 reference
Franco Mandelli
1 reference
Meral Beksac
1 reference
Roelof Willemze
1 reference
Boris Labar
1 reference
Jean-Pierre Marie
1 reference
Martin Mistrik
1 reference
Francesco Nobile
1 reference
Marco Sborgia
1 reference
Andrea Camera
1 reference
Francois Lefrère
1 reference
Simona Sica
1 reference
Nicola Cantore
1 reference
Xavier Thomas
1 reference
Jose E Guimaraes
1 reference
Pietro Leoni
1 reference
Maria E Mitra
1 reference
Dominique Bron
1 reference
Georges Fillet
1 reference
Erik W A Marijt
1 reference
Marco Mancini
1 reference
Joop Jansen
1 reference
Silvia M Trisolini
1 reference
Theo de Witte
1 reference
2 December 2013
1 reference
1 reference
32
1 reference
3
1 reference
219-228
1 reference
Identifiers
1 reference
1 reference